| Establishment and functioning of intrathymic microenvironments G Anderson, WE Jenkinson, T Jones, SM Parnell, FAM Kinsella, AJ White, ... Immunological reviews 209 (1), 10-27, 2006 | 139 | 2006 |
| NK cells produce high levels of IL‐10 early after allogeneic stem cell transplantation and suppress development of acute GVHD YLT Chan, J Zuo, C Inman, W Croft, J Begum, J Croudace, F Kinsella, ... European journal of immunology 48 (2), 316-329, 2018 | 45 | 2018 |
| Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic … E Nikolousis, S Robinson, S Nagra, C Brookes, F Kinsella, S Tauro, ... Leukemia research 37 (5), 561-565, 2013 | 37 | 2013 |
| The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT L Maggs, F Kinsella, YLT Chan, S Eldershaw, D Murray, J Nunnick, J Bird, ... Blood Advances 1 (19), 1589-1597, 2017 | 29 | 2017 |
| Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells FAM Kinsella, J Zuo, CF Inman, H Pearce, L Maggs, SE Eldershaw, ... Blood advances 3 (5), 734-743, 2019 | 25 | 2019 |
| PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity HM Parry, AC Dowell, J Zuo, K Verma, FAM Kinsella, J Begum, W Croft, ... PLoS pathogens 17 (3), e1009349, 2021 | 17 | 2021 |
| Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease FAM Kinsella, CF Inman, A Gudger, YT Chan, DJ Murray, J Zuo, G McIlroy, ... Leukemia research 83, 106173, 2019 | 13 | 2019 |
| Unique features and clinical importance of acute alloreactive immune responses CF Inman, SA Eldershaw, JE Croudace, NJ Davies, A Sharma-Oates, ... JCI insight 3 (10), 2018 | 11 | 2018 |
| Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective … Y Chalandon, G Sbianchi, L Gras, L Koster, J Apperley, J Byrne, ... American journal of hematology 98 (1), 112-121, 2023 | 10 | 2023 |
| Impact of donor-derived CD34+ infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic … T Czerw, S Iacobelli, V Malpassuti, L Koster, N Kröger, M Robin, ... Bone marrow transplantation 57 (2), 261-270, 2022 | 10 | 2022 |
| Lymphopenia-induced lymphoproliferation drives activation of naive T cells and expansion of regulatory populations S Eldershaw, K Verma, W Croft, T Rai, FAM Kinsella, C Stephens, H Chen, ... Iscience 24 (3), 2021 | 8 | 2021 |
| Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor FAM Kinsella, MRA Kashipaz, J Scarisbrick, R Malladi Case Reports 2017, bcr2016216331, 2017 | 6 | 2017 |
| CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire N Hassan, S Eldershaw, C Stephens, F Kinsella, C Craddock, R Malladi, ... Frontiers in immunology 13, 935949, 2022 | 4 | 2022 |
| “I just wanted to speak to someone-and there was no one…”: using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipients I Litchfield, MJ Calvert, F Kinsella, N Sungum, OL Aiyegbusi Orphanet Journal of Rare Diseases 18 (1), 86, 2023 | 3 | 2023 |
| Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic stem cell tranplantation is predictive of subsequent relapse and survival K Verma, W Croft, H Pearce, J Zuo, C Stephens, J Nunnick, FAM Kinsella, ... Haematologica 108 (2), 433, 2023 | 2 | 2023 |
| UK national audit of extracorporeal photopheresis (ECP) in chronic graft versus host disease FAM Kinsella, A Bencito, D Kulik, E Hurst, M Gilleece, JA Snowden, ... Leukemia & Lymphoma 61 (14), 3511-3514, 2020 | 2 | 2020 |
| Split Mixed Donor Chimerism Early after T-Cell Depleted Reduced Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation Predicts Survival FAM Kinsella, A Gudger, CF Inman, G Mc Ilroy, S Nagra, J Nunnick, ... Blood 124 (21), 423, 2014 | 2 | 2014 |
| Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label … CS Goodyear, A Patel, E Barnes, M Willicombe, S Siebert, TI de Silva, ... The Lancet Rheumatology 6 (6), e339-e351, 2024 | 1 | 2024 |
| Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT A Rovó, L Gras, B Piepenbroek, N Kröger, HC Reinhardt, A Radujkovic, ... American journal of hematology 99 (2), 203-215, 2024 | 1 | 2024 |
| OUTCOMES OF CMML PATIENTS UNDERGOING ALLOGENEIC HCT IN COMPARISON WITH MDS PATIENTS-A RETROSPECTIVE ANALYSIS ON BEHALF OF THE CMWP OF THE EBMT A Rovo, L Gras, B Piepenbroek, N Kroeger, HC Reinhardt, A Radujkovic, ... BONE MARROW TRANSPLANTATION 58 (SUPP1), 48-49, 2023 | 1 | 2023 |
